414 related articles for article (PubMed ID: 26471014)
21. Effects of eicosapentaenoic acid on hepatic dyslipidemia and oxidative stress in high fat diet-induced steatosis.
Hirotani Y; Ozaki N; Tsuji Y; Urashima Y; Myotoku M
Int J Food Sci Nutr; 2015; 66(5):569-73. PubMed ID: 26017323
[TBL] [Abstract][Full Text] [Related]
22. Differential effects of EPA, DPA and DHA on cardio-metabolic risk factors in high-fat diet fed mice.
Guo XF; Sinclair AJ; Kaur G; Li D
Prostaglandins Leukot Essent Fatty Acids; 2018 Sep; 136():47-55. PubMed ID: 29113747
[TBL] [Abstract][Full Text] [Related]
23. Treatment of Nonalcoholic Fatty Liver Disease with Long-Chain n-3 Polyunsaturated Fatty Acids in Humans.
Kelley NS
Metab Syndr Relat Disord; 2016 Nov; 14(9):417-430. PubMed ID: 27710160
[TBL] [Abstract][Full Text] [Related]
24. Long-term dietary supplementation with saury oil attenuates metabolic abnormalities in mice fed a high-fat diet: combined beneficial effect of omega-3 fatty acids and long-chain monounsaturated fatty acids.
Yang ZH; Inoue S; Taniguchi Y; Miyahara H; Iwasaki Y; Takeo J; Sakaue H; Nakaya Y
Lipids Health Dis; 2015 Dec; 14():155. PubMed ID: 26627187
[TBL] [Abstract][Full Text] [Related]
25. Extra virgin olive oil improved body weight and insulin sensitivity in high fat diet-induced obese LDLr-/-.Leiden mice without attenuation of steatohepatitis.
Álvarez-Amor L; Sierra AL; Cárdenas A; López-Bermudo L; López-Beas J; Andújar E; Pérez-Alegre M; Gallego-Durán R; Varela LM; Martin-Montalvo A; Berná G; Rojas A; Robles-Frías MJ; Hmadcha A; Romero-Gómez M; Kleemann R; Martín F
Sci Rep; 2021 Apr; 11(1):8250. PubMed ID: 33859314
[TBL] [Abstract][Full Text] [Related]
26. Adzuki bean ameliorates hepatic lipogenesis and proinflammatory mediator expression in mice fed a high-cholesterol and high-fat diet to induce nonalcoholic fatty liver disease.
Kim S; Hong J; Jeon R; Kim HS
Nutr Res; 2016 Jan; 36(1):90-100. PubMed ID: 26773785
[TBL] [Abstract][Full Text] [Related]
27. Pu-erh tea extract ameliorates high-fat diet-induced nonalcoholic steatohepatitis and insulin resistance by modulating hepatic IL-6/STAT3 signaling in mice.
Cai X; Fang C; Hayashi S; Hao S; Zhao M; Tsutsui H; Nishiguchi S; Sheng J
J Gastroenterol; 2016 Aug; 51(8):819-29. PubMed ID: 26794005
[TBL] [Abstract][Full Text] [Related]
28. Liver Protective Effects of Extra Virgin Olive Oil: Interaction between Its Chemical Composition and the Cell-signaling Pathways Involved in Protection.
Soto-Alarcon SA; Valenzuela R; Valenzuela A; Videla LA
Endocr Metab Immune Disord Drug Targets; 2018; 18(1):75-84. PubMed ID: 29141573
[TBL] [Abstract][Full Text] [Related]
29. Protective effects of extra virgin olive oil and exercise training on rat skeletal muscle against high-fat diet feeding.
Yeo D; Zhang T; Liu T; Zhang Y; Kang C; Ji LL
J Nutr Biochem; 2022 Feb; 100():108902. PubMed ID: 34748920
[TBL] [Abstract][Full Text] [Related]
30. Different Effects of Eicosapentaenoic and Docosahexaenoic Acids on Atherogenic High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice.
Suzuki-Kemuriyama N; Matsuzaka T; Kuba M; Ohno H; Han SI; Takeuchi Y; Isaka M; Kobayashi K; Iwasaki H; Yatoh S; Suzuki H; Miyajima K; Nakae D; Yahagi N; Nakagawa Y; Sone H; Yamada N; Shimano H
PLoS One; 2016; 11(6):e0157580. PubMed ID: 27333187
[TBL] [Abstract][Full Text] [Related]
31. The Glucagon-Like Peptide-1 Analogue Liraglutide Inhibits Oxidative Stress and Inflammatory Response in the Liver of Rats with Diet-Induced Non-alcoholic Fatty Liver Disease.
Gao H; Zeng Z; Zhang H; Zhou X; Guan L; Deng W; Xu L
Biol Pharm Bull; 2015; 38(5):694-702. PubMed ID: 25947915
[TBL] [Abstract][Full Text] [Related]
32. Crosstalk mechanisms in hepatoprotection: Thyroid hormone-docosahexaenoic acid (DHA) and DHA-extra virgin olive oil combined protocols.
Valenzuela R; Videla LA
Pharmacol Res; 2018 Jun; 132():168-175. PubMed ID: 29253525
[TBL] [Abstract][Full Text] [Related]
33. Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation.
Andrade JM; Paraíso AF; de Oliveira MV; Martins AM; Neto JF; Guimarães AL; de Paula AM; Qureshi M; Santos SH
Nutrition; 2014; 30(7-8):915-9. PubMed ID: 24985011
[TBL] [Abstract][Full Text] [Related]
34. Attenuation of High-Fat Diet-Induced Rat Liver Oxidative Stress and Steatosis by Combined Hydroxytyrosol- (HT-) Eicosapentaenoic Acid Supplementation Mainly Relies on HT.
Echeverría F; Valenzuela R; Bustamante A; Álvarez D; Ortiz M; Soto-Alarcon SA; Muñoz P; Corbari A; Videla LA
Oxid Med Cell Longev; 2018; 2018():5109503. PubMed ID: 30057681
[TBL] [Abstract][Full Text] [Related]
35. Diet switch and omega-3 hydroxy-fatty acids display differential hepatoprotective effects in an obesity/nonalcoholic fatty liver disease model in mice.
Rodriguez-Echevarria R; Macias-Barragan J; Parra-Vargas M; Davila-Rodriguez JR; Amezcua-Galvez E; Armendariz-Borunda J
World J Gastroenterol; 2018 Jan; 24(4):461-474. PubMed ID: 29398867
[TBL] [Abstract][Full Text] [Related]
36. Silybum marianum oil attenuates hepatic steatosis and oxidative stress in high fat diet-fed mice.
Zhu SY; Jiang N; Yang J; Tu J; Zhou Y; Xiao X; Dong Y
Biomed Pharmacother; 2018 Apr; 100():191-197. PubMed ID: 29428667
[TBL] [Abstract][Full Text] [Related]
37. Ameliorative effect of nicorandil on high fat diet induced non-alcoholic fatty liver disease in rats.
Elshazly SM
Eur J Pharmacol; 2015 Feb; 748():123-32. PubMed ID: 25542756
[TBL] [Abstract][Full Text] [Related]
38. Euterpe oleracea Mart.-Derived Polyphenols Protect Mice from Diet-Induced Obesity and Fatty Liver by Regulating Hepatic Lipogenesis and Cholesterol Excretion.
de Oliveira PR; da Costa CA; de Bem GF; Cordeiro VS; Santos IB; de Carvalho LC; da Conceição EP; Lisboa PC; Ognibene DT; Sousa PJ; Martins GR; da Silva AJ; de Moura RS; Resende AC
PLoS One; 2015; 10(12):e0143721. PubMed ID: 26630290
[TBL] [Abstract][Full Text] [Related]
39. Eicosapentaenoic and docosahexaenoic acid-enriched high fat diet delays the development of fatty liver in mice.
Soni NK; Nookaew I; Sandberg AS; Gabrielsson BG
Lipids Health Dis; 2015 Jul; 14():74. PubMed ID: 26193881
[TBL] [Abstract][Full Text] [Related]
40. Targeting n-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease.
Valenzuela R; Ortiz M; Hernández-Rodas MC; Echeverría F; Videla LA
Curr Med Chem; 2020; 27(31):5250-5272. PubMed ID: 30968772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
